Contact Person : Customer Services; Last Date for the submission of abstract : 24-Jun-2019; Clinically Advancing the Next Generation of Safe and Effective Multi-Specific Immune Cell Engaging Antibody Therapies for Solid Tumor Indications. Time: 9:00 am to 5:00 pm.